Vertex Pharmaceuticals Inc. buy TD Cowen
Start price
23.07.24
/
50%
€451.85
Target price
23.07.25
€460.55
Performance (%)
-10.92%
End price
24.07.25
€402.50
Summary
This prediction ended on 24.07.25 with a price of €402.50. The price of Vertex Pharmaceuticals Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -10.92%. TD_Cowen has a follow-up prediction for Vertex Pharmaceuticals Inc. where he still thinks Vertex Pharmaceuticals Inc. is a Buy. TD_Cowen has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vertex Pharmaceuticals Inc. | 3.638% | 3.638% | 40.954% |
| iShares Core DAX® | -0,87 % | 5,32 % | 6,86 % |
| iShares Nasdaq 100 | -0,38 % | 1,98 % | 25,70 % |
| iShares Nikkei 225® | -1,68 % | 1,95 % | 41,44 % |
| iShares S&P 500 | -0,65 % | 2,07 % | 21,40 % |
Comments by TD_Cowen for this prediction
In the thread Trading Vertex Pharmaceuticals Inc.
Die von TD_Cowen gewählte maximale Laufzeit wurde überschritten
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at TD Cowen from $450.00 to $500.00. They now have a "buy" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Current prediction by TD_Cowen for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€421.30
04.08.26
04.08.26
-
04.08.27
04.08.27
12.25%
19.08.26
19.08.26
